Cardiovascular Pathology Institute, Gaithersburg, Maryland.
Cardiovascular Pathology Institute, Gaithersburg, Maryland; University of Maryland, School of Medicine, Baltimore, Maryland.
JACC Cardiovasc Imaging. 2018 Jan;11(1):127-142. doi: 10.1016/j.jcmg.2017.10.012.
Coronary artery calcification is concomitant with the development of advanced atherosclerosis. Coronary artery calcification pathologically begins as microcalcifications (0.5 to 15.0 μm) and grows into larger calcium fragments, which eventually result in sheet-like deposits (>3 mm). This evolution is observed to occur concurrently with the progression of plaque. These fragments and sheets of calcification can be easily identified by radiography as well as by computed tomography and intravascular imaging. Many imaging modalities have proposed spotty calcification to be a predictor of unstable plaque and have suggested more extensive calcification to be associated with stable plaques and perhaps the use of statin therapy. We will review the pathology of coronary calcification in humans with a focus on risk factors, relationship with plaque progression, correlation with plaque (in)stability, and effect of pharmacologic interventions.
冠状动脉钙化伴随着动脉粥样硬化的进展而发生。冠状动脉钙化在病理上首先表现为微钙化(0.5 至 15.0μm),然后逐渐形成更大的钙碎片,最终导致片状沉积(>3mm)。这种演变与斑块的进展同时发生。这些钙碎片和片状沉积物可以通过放射学以及计算机断层扫描和血管内成像很容易地识别出来。许多影像学方法提出点状钙化是不稳定斑块的预测因子,并表明更广泛的钙化与稳定斑块有关,也许可以使用他汀类药物治疗。我们将重点讨论与冠状动脉钙化相关的危险因素、与斑块进展的关系、与斑块(稳定/不稳定)的相关性以及药物干预的效果,来回顾人类冠状动脉钙化的病理学。